Bookbuilding IPO | ₹130 Cr | Listed at BSE, NSE | Mon, Jun 3, 2024 - Wed, Jun 5, 2024
Kronox Lab Sciences IPO is a book build issue of ₹130.15 crores. The issue is entirely an offer for sale of 0.96 crore shares of ₹130.15 crore.
Kronox Lab Sciences IPO bidding started from Jun 3, 2024 and ended on Jun 5, 2024. The allotment for Kronox Lab Sciences IPO was finalized on Jun 6, 2024. The shares got listed on BSE, NSE on Jun 10, 2024.
Kronox Lab Sciences IPO price band is set at ₹136 per share. The lot size for an application is 110. The minimum amount of investment required by an retail is ₹14,960 (110 shares) (based on upper price). The lot size investment for sNII is 14 lots (1,540 shares), amounting to ₹2,09,440, and for bNII, it is 67 lots (7,370 shares), amounting to ₹10,02,320.
Pantomath Capital Advisors Pvt.Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Kronox Lab Sciences IPO RHP for detailed Information.
IPO Open
Mon, Jun 3, 2024
IPO Close
Wed, Jun 5, 2024
Issue Price
₹136 per share
Market Cap (Pre-IPO)
₹504.61 Cr
| IPO Date | 3 to 5 Jun, 2024 |
| Listed on | Mon, Jun 10, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹129 to ₹136 |
| Issue Price | ₹136 per share |
| Lot Size | 110 Shares |
| Sale Type | OFS only |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 95,70,000 shares (agg. up to ₹130 Cr) |
| Offer for Sale | 95,70,000 shares of ₹10 (agg. up to ₹130 Cr) |
| Share Holding Pre Issue | 3,71,04,000 shares |
| Share Holding Post Issue | 3,71,04,000 shares |
| BSE Script Code / NSE Symbol | 544187 / KRONOX |
| ISIN | INE0ATZ01017 |
Kronox Lab Sciences IPO offers total 95,70,000 shares. Out of which 47,85,000 (50.00%) allocated to QIB, 19,14,000 (20.00%) allocated to QIB (Ex- Anchor), 14,35,500 (15.00%) allocated to NII 33,49,500 (35.00%) allocated to RII and 28,71,000 (30.00%) allocated to Anchor investors.
| Investor Category | Shares Offered | Max Allottees |
|---|---|---|
| QIB Shares Offered | 47,85,000 (50.00%) | NA |
| − Anchor Investor Shares Offered | 28,71,000 (30.00%) | NA |
| − QIB (Ex. Anchor) Shares Offered | 19,14,000 (20.00%) | NA |
| NII (HNI) Shares Offered | 14,35,500 (15.00%) | NA |
| − bNII > ₹10L | 9,57,000 (10.00%) | 621 |
| − sNII < ₹10L | 4,78,500 (5.00%) | 310 |
| Retail Shares Offered | 33,49,500 (35.00%) | 30,450 |
| Total Shares Offered | 95,70,000 (100.00%) |
Investors can bid for a minimum of 110 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 110 | ₹14,960 |
| Retail (Max) | 13 | 1,430 | ₹1,94,480 |
| S-HNI (Min) | 14 | 1,540 | ₹2,09,440 |
| S-HNI (Max) | 66 | 7,260 | ₹9,87,360 |
| B-HNI (Min) | 67 | 7,370 | ₹10,02,320 |
Kronox Lab Sciences IPO raises ₹39.05 crore from anchor investors. Kronox Lab Sciences IPO Anchor bid date is May 31, 2024.
📝 Anchor Investors Letter (PDF)
| Bid Date | Fri, May 31, 2024 |
| Shares Offered | 28,71,000 |
| Anchor Portion (₹ Cr.) | 39.05 |
| Anchor lock-in period end date for 50% shares (30 Days) | Sat, Jul 6, 2024 |
| Anchor lock-in period end date for remaining shares (90 Days) | Wed, Sep 4, 2024 |
Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company's High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.
The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.
The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.
The company has three manufacturing facilities in Vadodara, Gujarat, close to the seaports of Mundra, Kandla, Hazira, and Nhava Sheva. The facilities cover 17,454 sq. m. and have an installed capacity of 7,242 TPA as of December 31, 2023. Unit I/II holds FSSC 22000 (Version 5), ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications. Additionally, some products manufactured at Unit I have obtained Kosher, Halal, GMP, and GLP certifications.
As of December 31, 2023, the company is conducting research and development on 122 products.
The company has served over 592 customers in the past three years. By December 31, 2023, 141 customers of the total, placed repeat orders.
As of December 31, 2023, the company employees 212 people at various levels.
| Period Ended | 31 Dec 2023 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 66.96 | 54.03 | 56.79 | 37.65 |
| Total Income | 68.44 | 97.50 | 83.34 | 63.24 |
| Profit After Tax | 15.47 | 16.62 | 13.63 | 9.73 |
| NET Worth | 60.28 | 44.68 | 40.35 | 26.81 |
| Reserves and Surplus | 15.56 | 7.58 | 40.11 | 26.57 |
| Total Borrowing | 0.64 | 0.01 | ||
| Amount in ₹ Crore | ||||
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Achieve the benefits of listing the Equity Shares on the Stock Exchanges |
| KPI | Dec 31, 2023 |
|---|---|
| ROE | 25.66% |
| ROCE | 33.15% |
| RoNW | 25.66% |
| PAT Margin | 22.60% |
| Price to Book Value | 8.37 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 4.48 | 5.56 |
| P/E (x) | 30.37 | 24.47 |
| Promoter Holding | 99.98% | 74.21% |
| Market Cap | ₹504.61 Cr. |
The Kronox Lab Sciences IPO is subscribed 117.25 times on June 5, 2024 6:19:05 PM (Day 3). The public issue subscribed 54.24 times in the retail category, 89.03 times in the QIB category, and 301.92 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (x) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB (Ex Anchor) | 89.03 | 19,14,000 | 17,04,09,360 |
| NII | 301.92 | 14,35,500 | 43,34,02,530 |
| bNII (> ₹10L) | 322.26 | 9,57,000 | 30,84,06,670 |
| sNII (< ₹10L) | 261.22 | 4,78,500 | 12,49,95,860 |
| Retail | 54.24 | 33,49,500 | 18,16,61,810 |
| Total | 117.25 | 66,99,000 | 78,54,73,700 |
Total Applications: 15,28,029
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Fees payable to Book Running Lead Manager | 2.03 |
| 2 | Underwriting / Selling Commission | 6.51 |
| 3 | Commission/Processing fees payable to SCSBs, Sponsor Bank(s) and fees payable to sponsor bank(s) for bids made by RIBs, Bankers to the Offer(s), Brokerage and Syndicate fees, bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs | 1.63 |
| 4 | Fees payable to the Registrar to the Offer | 0.21 |
| 5 | Fees payable to Statutory Auditors | 0.02 |
| 6 | Fees payable to Independent Chartered Accountant | 0.02 |
| 7 | Fees payable to Independent Chartered Engineer | 0.01 |
| 8 | Fees payable to Industry Service Provider | 0.13 |
| 9 | Others including but not limited to: (i) Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses; (ii) Printing and distribution of stationery; (iii) Advertising and marketing expenses; (iv) Fees payable to legal counsel; (v) Fees payable to other advisors to the Offer, if any; and (vi) Miscellaneous expenses | 2.32 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹136.00 | ₹136.00 |
| Open | ₹165.00 | ₹164.95 |
| Low | ₹156.80 | ₹156.70 |
| High | ₹165.00 | ₹165.60 |
| Last Trade | ₹159.35 | ₹159.32 |
Lead Manager Reports
Kronox Lab Sciences IPO is a main-board IPO of 95,70,000 equity shares of the face value of ₹10 aggregating up to ₹130 Crores. The issue is priced at ₹136 per share. The minimum order quantity is 110.
The IPO opens on Mon, Jun 3, 2024, and closes on Wed, Jun 5, 2024.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Kronox Lab Sciences IPO using UPI as a payment gateway. Zerodha customers can apply in Kronox Lab Sciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Kronox Lab Sciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Kronox Lab Sciences IPO opens on Mon, Jun 3, 2024 and closes on Wed, Jun 5, 2024.
Kronox Lab Sciences IPO lot size is 110, and the minimum amount required for application is ₹14,960.
You can apply in Kronox Lab Sciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Kronox Lab Sciences IPO will be done on Thursday, June 6, 2024, and the allotted shares will be credited to your demat account by Fri, Jun 7, 2024. Check the Kronox Lab Sciences IPO allotment status.
The Kronox Lab Sciences IPO listing date is on Mon, Jun 10, 2024.
